Ardea Biosciences (RDEA) Inactive USPTO patentsUtility application

The present invention relates to pharmaceutical compositions containing 2-((3-(4-cyanonaphthalen-1-yl)pyridine-4-yl)thio)-2-methylpropanoic acid or a pharmaceutically acceptable salt (hereinafter referred to as the “Agent”), more particularly to orally deliverable compositions containing the Agent; to the use of said compositions as a medicament; and to processes for the preparation of said compositions.

Described herein are compounds useful in the modulation of blood uric acid levels, formulations containing them and methods of using them.